febrile

Febrile #64 – Revenge of the Cyst

64 Cover Art OPT

Summary

Drs. Cesar Berto and Christina Coyle discuss a case of brain calcifications

Table of Contents

Credits

Host(s): Cesar Berto, Sara Dong

Guest: Christina Coyle

Writing: Cesar Berto, Sara Dong

Producing/Editing/Cover Art/Infographics: Sara Dong

Our Guests

Guest Co-Host

Cesar Berto, MD

Dr. Cesar Berto is currently a first year adult infectious diseases fellow in the Massachusetts General / Brigham and Women’s Hospital ID program.  He completed his medical school training at Universidad Nacional Mayor de San Marcos Facultad de Medicina San Fernando.  He completed residency and chief residency at NYC Health & Hospitals/Jacobi Medical Center, Albert Einstein College of Medicine

Christina Coyle, M.D., M.S.

Christina Coyle, M.D., M.S. is a board-certified physician in Infectious Disease and has practiced Tropical Medicine for over twenty-five years in New York City (NYC). She is a Full Professor in the Department of Medicine and Pathology at the Albert Einstein College of Medicine and is recognized as an expert in Tropical Medicine. She serves as the Director of the Clinical Infectious Disease Service at Jacobi Medical Center, and oversees the largest Tropical Medicine Clinic in the Bronx, NYC. Since 2007, she has been a site director for GeoSentinel, the global surveillance network of the International Society of Travel Medicine (ISTM) and the Centers for Disease Control and Prevention (CDC). Dr. Coyle is currently serving as an associate editor for Open Forum in Infectious Diseases (OFID). From 2016 to 2021, she served as a Member of the American Board of Internal Medicine’s Infectious Disease Exam Committee. Dr. Coyle is widely recognized as an expert on larval tapeworms, neurocysticercosis, and echinococcus, serving on both national and international committees for this disease. Since 2017, she has served on the Echinococcal WHO working group. Dr. Coyle is also a content expert for the Center for Disease and Prevention Control (CDC) for all complicated cases of echinococcus. She is a co-author on “Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).” She is the principal investigator for a CDC cooperative grant, “Reducing the burden of neglected parasitic infections (NPIs) in the United States through evidence-based prevention and control activities”.

Culture

Cesar shared that he recently watched Company, a remade musical by Steven Sondheim.

Christina shared that she is passionate about ballet, dance, and music.  She is obsessed with Freddie Mercury from Queen, who once danced with the Royal Ballet.

Consult Notes

Consult Q

Recommendations for work-up of brain calcification

Key Points

What is cysticercosis?

  • Cysticercosis is the disease associated with development of the larval stage of the pork tapeworm Taenia solium within an intermediate host
  • Clinical syndromes include neurocysticercosis and extraneural cysticercosis

Life Cycle and Transmission

CDC Life Cycle of Taenia solium

  • Swine are the usual intermediate host but humans (the usual definitive host) can also serve as accidental intermediate hosts following ingestion of eggs
  • Cysticercosis is only acquired from the fecal-oral route (ingestion of eggs), NOT via ingestion of cysticerci in undercooked pork (which is associated with intestinal taeniasis)
    • Infected pork contains larval cysts that develop into adult worms in the human intestine but does not contain the eggs that cause cysticercosis
    • Some patients with cysticercosis are tapeworm carriers but most individuals with intestinal taeniasis do not develop symptomatic cysticercosis. Human tapeworm carriers are at risk for fecal-oral autoinoculation of eggs though and subsequent development of cysticercosis

Clinical manifestations of cysticercosis

  • Tissue cysticerci develop over about 3-8 wks after ingestion of T.solium eggs
  • Phases of cysticercosis have been described as:
      • Initial (viable) phase: usually asymptomatic, very little inflammation in surrounding tissues, can persist in this stage for years
      • Early inflammatory stage
      • Degenerating phase
      • Nonviable phase
  • Christina emphasized that NCC is a pleomorphic disease, and that the clinical presentation is defined by the burden of disease, where disease is located, and the host inflammatory response
      • Generally intraparenchymal cysts are associated with seizures and/or headache
      • Extraparenchymal cysts are associated with symptoms of elevated intracranial pressure (headaches, nausea/vomiting) +/- altered mental status
      • Extraneural cysticercosis may involve a range of tissues but most commonly muscle or subcutaneous tissues
  • A few other notes to remember:
      • Cysticerci may occur simultaneously in more than one site
      • Cysticerci can be at different stages when they present (such as viable vs enhancing vs calcified)
  • In the US, most hospitalized patients with NCC present with a single enhancing lesion

Classification of neurocysticercosis

Christina explained that in her opinion, we shouldn’t approach all of neurocysticercosis as one disease – it acts very differently in different spaces of the brain.  Here are the general classifications though of NCC disease:

Intraparenchymal NCC:

  • Most common form (>60%) of cases
  • Onset typically 3-5 years after infection (but can occurs decades later)
  • Clinical manifestations depend on the number and location of cysticerci and the degree of associated inflammatory response
      • Seizures are the most common clinical manifestation of parenchymal NCC
          • Typically focal and may be associated with secondary generalization
          • May occur in setting of cyst degeneration (associated with enhancement on radiographic imaging) and/or in setting of nonviable cysticerci (associated with calcification on radiographic imaging) 
          • In many endemic settings, NCC is most common cause of adult onset seizures
      • Less commonly, might have: altered vision, focal neurologic signs, meningitis
      • Many parenchymal NCC cases are asymptomatic and identified incidentally via radiographic imaging for other reasons
  • Prognosis varies with number of cysticeri and degree of inflammation
      • Patients with single enhancing lesions have more favorable prognosis than those with multiple viable cysticerci

Extraparenchymal NCC:

  • Can occur in ventricles, subarachnoid space, spine, and/or eye
  • More common in adults than children
  • Symptoms of elevated ICP (HA, nausea, vomiting) +/- altered mental status
  • In general, extraparenchymal NCC carries higher risk of complication or death than parenchymal disease
  • Intraventricular lesions (free floating cysts in ventricular cavity or attached to choroid plexus) = 10-20% of cases
      • Typically symptoms develop when cysticerci lodge in ventricular outflow tracks with consequent obstructive hydrocephalus and increased ICP (gradual or acute onset)
      • Headache, nausea, vomiting, altered mental status, decreased visual acuity with papilledema
      • Less frequently can see seizures and focal neurologic signs
      • Occasionally mobile cysts in third and fourth ventricle can cause intermittent obstruction, leading to episodes of sudden loss of consciousness related to head movements (Bruns’ syndrome)
  • Subarachnoid lesions in basilar cisterns is most severe form = ~5% of hospitalized cases
      • In some SAN, cysts have lost scolex and may consist of cluster of proliferating membranes (referred to as racemose cysticercosis)
      • May be associated with chronic arachnoiditis and/or mass effect due to cyst enlargement
  • Spinal lesions ~1% of cases, usually in subarachnoid space where cause inflammatory and demyelinating changes in peripheral nerve roots >> radicular pain, paresthesias, and/or sphincter disturbances
  • Orbital and ocular lesions, rare, observed almost exclusively in India

*Extraparenchymal and intraparenchymal disease can coexist*

Diagnosis of neurocysticercosis

Management of Taenia solium neurocysticercosis

Prevention of cysticercosis

Here are a few strategies to consider for targeting stages of transmission:

  • Prevent human tapeworm infection to reduce the reservoir of egg carriers:
      • Eliminate human consumption of pork contaminated with viable cysticerci >> Christina mentioned how it can be helpful to show patients imaging of pork with cysticerci, which are visible in raw meat (“measly” or “measled” meat)
      • Freezing or cooking meat can destroy cysticerci, but pickling and salting will not
      • Provide education about routes of transmission and proper hygiene prior to food preparation
      • Treating human tapeworm carriers
  • Prevent transmission of infections in pigs, such as eliminating access of pigs to human fecal material (disposal of human waste with latrines or sewage systems) and confining pigs so they are not roaming freely [this can be costly though]

Goal

Listeners will be able to understand the epidemiology, life cycle, and risk factors for neurocysticercosis

Learning Objectives

After listening to this episode, listeners will be able to:

  • Describe the life cycle of Taenia solium
  • Describe the typical clinical manifestations and imaging findings of neurocysticercosis
  • Discuss the management of neurocysticercosis including antiparasitic medication and corticosteroids

Disclosures

Our guests (Cesar Berto and Christina Coyle) as well as Febrile podcast and hosts report no relevant financial disclosures

Citation

Coyle, C., Berto, C., Dong, S. “#64: Revenge of the Cyst”. Febrile: A Cultured Podcast. https://player.captivate.fm/episode/a9952e58-86f0-476e-8546-547125a7887e

Transcript

Scroll to Top